Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE S W DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
Head-to-head clinical analysis: ISOLYTE S W DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE R IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Isolyte S with Dextrose 5% is an intravenous solution providing electrolytes and calories. Dextrose supplies glucose for cellular energy metabolism, while electrolytes (sodium, potassium, magnesium, chloride, acetate, gluconate) maintain acid-base balance and osmotic pressure. Acetate and gluconate are metabolized to bicarbonate, providing alkalinizing effect.
Plasma-Lyte R provides electrolytes and water to maintain or restore fluid balance, with bicarbonate precursors (acetate, gluconate) to buffer metabolic acidosis.
Intravenous infusion; dose determined by fluid and electrolyte requirements. Typical adult maintenance: 100-200 mL/h (2.4-4.8 L/day) depending on clinical status.
Intravenous infusion at a rate of 25-50 mL/kg body weight per 24 hours, adjusted for fluid and electrolyte needs. Typical adult maintenance dose: 1-2 L/day.
None Documented
None Documented
Not applicable for the combination; individual components: dextrose has an elimination half-life of 15-20 minutes, electrolytes are not eliminated as a drug.
Not applicable (Plasma-Lyte R components are endogenous electrolytes and water; administered crystalloid redistributes rapidly; half-life of approximately 20-30 minutes for volume expansion due to renal excretion and redistribution into interstitial space)
Renal excretion of electrolytes and water; dextrose is metabolized to CO2 and water, with <0.5% excreted unchanged in urine.
Renal: >90% (electrolytes and water); Biliary/fecal: negligible (<5%)
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution